3.815
1.16%
0.075
전일 마감가:
$3.74
열려 있는:
$3.78
하루 거래량:
999.26K
Relative Volume:
0.28
시가총액:
$429.56M
수익:
$4.21M
순이익/손실:
$-97.67M
주가수익비율:
-4.1022
EPS:
-0.93
순현금흐름:
$-70.76M
1주 성능:
-9.27%
1개월 성능:
+42.77%
6개월 성능:
-10.56%
1년 성능:
-1.86%
Absci Corp Stock (ABSI) Company Profile
명칭
Absci Corp
전화
(360) 949-1041
주소
18105 SE MILL PLAIN BLVD, VANCOUVER
ABSI을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.80 | 429.56M | 4.21M | -97.67M | -70.76M | -0.93 |
VRTX
Vertex Pharmaceuticals Inc
|
439.29 | 113.70B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
680.29 | 75.52B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
662.88 | 39.78B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
275.25 | 35.34B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
120.90 | 29.05B | 3.30B | -501.07M | 1.03B | -2.1146 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-22 | 개시 | Needham | Buy |
2024-10-02 | 개시 | Guggenheim | Buy |
2024-07-03 | 개시 | Morgan Stanley | Overweight |
2024-03-14 | 개시 | Scotiabank | Sector Outperform |
2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
2023-05-04 | 개시 | H.C. Wainwright | Buy |
2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Underweight |
2022-07-18 | 개시 | Truist | Buy |
2022-03-02 | 재개 | Cowen | Market Perform |
2022-02-01 | 개시 | Berenberg | Buy |
2021-11-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2021-10-15 | 재개 | Cowen | Market Perform |
2021-08-16 | 개시 | BofA Securities | Neutral |
2021-08-16 | 개시 | Cowen | Market Perform |
2021-08-16 | 개시 | Credit Suisse | Outperform |
2021-08-16 | 개시 | Stifel | Hold |
모두보기
Absci Corp 주식(ABSI)의 최신 뉴스
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN
Ballentine Partners LLC Takes $27,000 Position in Absci Co. (NASDAQ:ABSI) - Defense World
Absci (NASDAQ:ABSI) Earns Buy Rating from Analysts at Needham & Company LLC - Defense World
Cathie Wood's ARK sells Accolade stock, buys more Absci - MSN
Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham - Insider Monkey
Cathie Wood's ARK sells Accolade stock, buys more Absci By Investing.com - Investing.com Australia
Absci Stock Surges with “Buy” Ratings from HC Wainwright and Guggenheim: What Investors Should Know - HPBL
Absci Corporation Soars 44% on Strategic AI Drug Discovery Partnership with AMD – Market - HPBL
Absci Corporation and AMD Partner to Revolutionize AI-Driven Drug Discovery – Market - HPBL
Absci (NASDAQ:ABSI) Now Covered by Needham & Company LLC - MarketBeat
Needham Initiates Coverage of Absci (ABSI) with Buy Recommendation - MSN
TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail
KBW Premium Yield Equity REIT Index (KYX) QuotePress Release - The Globe and Mail
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
KBW Regional Banking Index (KRX) QuotePress Release - The Globe and Mail
Absci shares jump as analyst lauds 'practical' AI drug company - The Business Journals
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales - Benzinga
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside - Benzinga
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings - Benzinga
Needham initiates Absci shares with Buy rating on strategy By Investing.com - Investing.com Canada
Needham initiates Absci shares with Buy rating on strategy - MSN
Needham & Company LLC Begins Coverage on Absci (NASDAQ:ABSI) - MarketBeat
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies - Benzinga
Absci Corp (ABSI-Q) QuotePress Release - The Globe and Mail
Absci Corporation Partners with AMD to Revolutionize AI-Powered Drug Discovery – Market - HPBL
Absci partners with semiconductor company AMD for AI drug discovery - Mobihealth News
Absci and Owkin synergise TechBio platforms to advance AI drug discovery - European Pharmaceutical Manufacturer
AMD and Absci Collaborate to Revolutionize AI-Driven Drug Discovery – Market - HPBL
Absci Co. (NASDAQ:ABSI) Short Interest Update - Defense World
Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership - MSN
Absci Shares Surge 27% on $20M Investment from AMD – Market - HPBL
Absci Co. (NASDAQ:ABSI) Short Interest Up 10.5% in December - MarketBeat
Barclays PLC Buys 104,083 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat
Complete List of All AI Companies Under $2 Billion Market Cap - Insider Monkey
Absci Corporation (ABSI): AI in Biopharma Discovery - Insider Monkey
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership By Investing.com - Investing.com South Africa
Absci Corporation Shares Surge on Strategic Partnership with AMD – Market - HPBL
Absci's (ABSI) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
I: Weekly TechBio News - substack.com
Thinking about buying stock in Hanryu Holdings, Absci Corp, Spero Therapeutics, BioXcel Therapeutics, or Cybin? - Marketscreener.com
Absci Looks Cheap And Positioned For Growth With AMD’s AI Backing (NASDAQ:ABSI) - Seeking Alpha
Absci rises after report on $20M investment by Advanced Micro Devices - MSN
Absci Raising $20 Million From AMD - Pulse 2.0
Catherine Wood's Strategic Acquisition of Absci Corp Shares - GuruFocus.com
ABSIAbsci Corporation Latest Stock News & Market Updates - StockTitan
Absci, Owkin announce partnership to bring together AI platforms - Yahoo Finance
Absci Corporation and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery - Marketscreener.com
Absci Corp (ABSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):